share_log

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Chidozie Ugwumba(19.9%)

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Chidozie Ugwumba(19.9%)

SC 13G/A：超過5%持股股東披露文件(修正)-Chidozie Ugwumba(19.9%)
美股SEC公告 ·  10/03 03:59
牛牛AI助理已提取核心訊息
Chidozie Ugwumba has filed an amended Schedule 13G with the Securities and Exchange Commission, disclosing a 19.9% ownership stake in Clene Inc., a biopharmaceutical company. The filing, dated September 30, 2024, indicates that Ugwumba beneficially owns 2,249,661 shares of Clene's common stock, which includes shares issuable upon the exercise of various warrants. The disclosure follows Ugwumba's resignation from Clene's board of directors on February 15, 2023, and asserts that his holding is for investment purposes and not intended to change or influence control of the company. The reported ownership percentage is based on the total number of Clene's shares outstanding as of September 30, 2024, plus additional shares that could be acquired through warrant exercises, subject to a cap that prevents ownership exceeding 19.9% of voting securities.
Chidozie Ugwumba has filed an amended Schedule 13G with the Securities and Exchange Commission, disclosing a 19.9% ownership stake in Clene Inc., a biopharmaceutical company. The filing, dated September 30, 2024, indicates that Ugwumba beneficially owns 2,249,661 shares of Clene's common stock, which includes shares issuable upon the exercise of various warrants. The disclosure follows Ugwumba's resignation from Clene's board of directors on February 15, 2023, and asserts that his holding is for investment purposes and not intended to change or influence control of the company. The reported ownership percentage is based on the total number of Clene's shares outstanding as of September 30, 2024, plus additional shares that could be acquired through warrant exercises, subject to a cap that prevents ownership exceeding 19.9% of voting securities.
Chidozie Ugwumba已向美國證券交易委員會提交了修訂後的13G表，披露他持有Clene Inc. 19.9%的股權。文件日期爲2024年9月30日，顯示Ugwumba有權擁有Clene普通股2,249,661股，其中包括可通過行使各種認股權形成的股份。披露跟隨Ugwumba於2023年2月15日從Clene董事會辭職，並聲明他的持股是爲投資目的，並無意改變或影響公司的控制。報道的持股比例基於2024年9月30日Clene現有股份總數，再加上通過認股權行使可能獲得的額外股份，但受限制以防止持股超過19.9%的表決證券。
Chidozie Ugwumba已向美國證券交易委員會提交了修訂後的13G表，披露他持有Clene Inc. 19.9%的股權。文件日期爲2024年9月30日，顯示Ugwumba有權擁有Clene普通股2,249,661股，其中包括可通過行使各種認股權形成的股份。披露跟隨Ugwumba於2023年2月15日從Clene董事會辭職，並聲明他的持股是爲投資目的，並無意改變或影響公司的控制。報道的持股比例基於2024年9月30日Clene現有股份總數，再加上通過認股權行使可能獲得的額外股份，但受限制以防止持股超過19.9%的表決證券。
有用
沒用

該公告為獨立文件：

獨立文件1

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。